46 Results for "

EphA2

" in MedChemExpress (MCE) Product Catalog:
Products (46)

46 Results for "EphA2" in MCE Product Catalog:

  • Isoforms Recommended:
  • Recombinant Proteins Recommended:
9
9 Publications Verification
Referencia número: HY-13258A
No. CAS: 940310-85-0
Pureza:  99.71%
Synonyms: BHG712
Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

NVP-BHG712 is an oral active EphB4 kinase autophosphorylation inhibitor, with IC50 values of 3.3 nM and 3.0 nM for EphA2 and EphB4, respectively [2].
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-13258
No. CAS: 2245892-85-5
Pureza:  99.58%
Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

NVP-BHG712 isomer, a regioisomer of NVP-BHG712, shows conserved non-bonded binding to EPHA2 and EPHB4 .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P10579
No. CAS: 2225868-19-7
Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

123B9, a tumor-homing agent, is a potent and selective EphA2 agonist with a Kd value of 4.0 μM. 123B9 selectively targets the EphA2 tyrosine kinase receptor ligand-binding domain. 123B9 does not appreciably inhibit the ligand binding domains of the most closely related EphA3 and EphA4 receptors .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-P70336
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuEphrin type-A receptor 2/EphA2, His; Ephrin type-A receptor 2; Epithelial cell kinase; Tyrosine-protein kinase receptor ECK; EphA2
Species:  
Source:  
loading...
    loading...
Referencia número: HY-P990627
Synonyms: MEDI-547 antibody

Áreas de investigación:  

Cancer

Anti-EphA2 Antibody (1C1) (MEDI-547 antibody) is an anti-EphA2 monoclonal antibody. Anti-EphA2 Antibody (1C1) can induce degradation of EphA2 protein. Anti-EphA2 Antibody (1C1) conjugated with McMMAF (HY-15578) can form an antibody-conjugated drugs, which has potent antitumor activity. Anti-EphA2 Antibody (1C1) can be used for the research of cancer, such as prostate cancer and glioma [2].
loading...
    loading...
Referencia número: HY-P991577
Synonyms: DS-8895A

Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

DS-8895(DS-8895A) is an anti-EphA2 monoclonal antibody with specific binding to EphA2 receptors and EphA2-expressing cells. DS-8895, when conjugated with 89Zr, 111In, or 125I, supports molecular imaging of EphA2 expression in xenograft models. DS-8895 allows noninvasive measurement of EphA2 expresssion in tumors in vivo. [2].
loading...
    loading...
Referencia número: HY-P10412
No. CAS: 2412926-30-6
Synonyms: ANXA1-derived 11 amino acid-long peptide
Áreas de investigación:  

Cancer

A11 (ANXA1-derived 11 amino acid-long peptide) is a ANXA1-EphA2 interaction-blocking peptide. A11 reduces ANXA1 bound to EphA2 and increases Cbl (the E3 ubiquitin ligase of EphA2) bound to EphA2. A11 inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells. A11 inhibits angiogenesis. A11 can be used in studies related to nasopharyngeal carcinoma .
loading...
    loading...
Referencia número: HY-147637
No. CAS: 2611459-57-3
Pureza:  99.32%
Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

EphA2 agonist 1 (Compound 7bg) is a potent EphA2 receptor agonist. EphA2 agonist 1 shows great potency and selectivity toward EphA2 overexpressed glioblastoma cells and stimulates EphA2 phosphorylation .
loading...
    loading...
Referencia número: HY-123607
No. CAS: 1639159-47-9
Pureza:  99.23%
Target:  

Ephrin Receptor

Áreas de investigación:  

Neurological Disease Cancer

UniPR129 is a potent and orally active Eph/ephrin antagonist. UniPR129 can inhibit EphA2-ephrin-A1 interaction with an IC50 of 945 nM and a Ki of 370 nM. UniPR129 can inhibit angiogenesis and show antitumor and neuroprotective effect. UniPR129 can be used for the researches of cancer and neurological disease, such as colorectal cancer and optic neuropathy [2] .
loading...
    loading...
Referencia número: HY-P3717
No. CAS: 3031514-44-7
Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

Targefrin is a potent EphA2-targeting agent, acts as an antagonist. Targefrin binds EphA2-LBD with 21 nM dissociation constant and an IC50 value of 10.8 nM. Targefrin induces cellular receptor internalization and degradation in several pancreatic cancer cell lines .
loading...
    loading...
Referencia número: HY-169849
No. CAS: 1428095-28-6
Target:  

Ephrin Receptor

Áreas de investigación:  

Others

EphA2 antagonist 1 (4b) is a bile acid conjugate and an ephrin type-A receptor 2 (EPHA2) inhibitor .
loading...
    loading...
Referencia número: HY-133178
No. CAS: 131086-98-1
Pureza:  99.72%
Synonyms: 3,4,8,9-Tetrahydroxy urolithin
Urolithin D (3,4,8,9-Tetrahydroxy urolithin) is a colonic metabolite of Ellagitannins and a competitive, reversible, and selective antagonist of the EphA receptor. Urolithin D inhibits EphA2-ephrin-A1 binding with an IC50 of 0.9 μM. Urolithin D is also a potent antioxidant that scavenges free radicals and repairs oxidized DNA damage. Additionally, Urolithin D suppresses triglyceride accumulation and promotes fatty acid oxidation by activating the AMPK signaling pathway. Urolithin D can be used for research on tumors, metabolic, and inflammatory diseases [2] .
loading...
    loading...
Referencia número: HY-124813
No. CAS: 2083618-79-3
Pureza:  99.29%
Synonyms: 113B7
Target:  

FAK EGFR MMP NF-κB SDCBP

Áreas de investigación:  

Cancer

PDZ1i (113B7) is a inhibitor of MDA-9/Syntenin, with selective binding to the PDZ1 domain. PDZ1i inhibits radiation-induced invasion of glioblastoma (GBM) cells, radiosensitizes GBM cells, and impairs GBM-related signaling pathways (including Src/EphA2, EGFRvIII/FAK, and NF-κB). PDZ1i reduces radiation-induced secretion of invasion-related proteases (MMP-2, MMP-9, ADAM9). PDZ1i shows anti-tumor effects in nude mice bearing intracranial U1242-luc xenografts or GBM xenografts. PDZ1i can be used for the study of glioblastoma (GBM), breast cancer and prostate cancer [2] .
loading...
    loading...
Referencia número: HY-170517
No. CAS: 3065631-84-4
Target:  

Wee1 Ephrin Receptor

Áreas de investigación:  

Cancer

PKMYT1-IN-8 (Compound 137) is the inhibitor for PKMYT1 with an IC50 of 9 nM. PKMYT1-IN-8 inhibits EPHB3, EPHA1, KIT, EPHB1, EPHA2, EPHA3, and EPHB2with IC50s of 1.79, 3.17, 4.29, 6.32, 6.83, 8.10, and 10.9 μM, respectively. PKMYT1-IN-8 inhibits the proliferation of cancer cell OVCAR3 with GI50 of 2.02 μM .
loading...
    loading...
Referencia número: HY-146141
No. CAS: 2169273-66-7
Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

EphA2 agonist 2 (Lead compound) is a selective EphA2 agonist with antitumor activities. EphA2 agonist 2 can cross the BBB .
loading...
    loading...
Referencia número: HY-146375
No. CAS: 2938227-14-4
Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

UniPR505 (Compound 14) is an EphA2 antagonist with an IC50 of 0.95 µM. UniPR505 displays anti-angiogenic properties .
loading...
    loading...
Referencia número: HY-W078239
No. CAS: 313701-92-7
Target:  

Ephrin Receptor

Áreas de investigación:  

Cancer

EPHA4 antagonist-1 (Compound 2) is an EphA4 receptor antagonist. EPHA4 antagonist-1 is also an EphA2 receptor antagonist. EPHA4 antagonist-1 inhibits ephrin-A5 AP binding to EphA4 Fc receptor, with an IC50 of 10 μM .
loading...
    loading...
Referencia número: HY-159174
Áreas de investigación:  

Infection

EPHA2/A4/GAK-IN-1 (compound 55) is a potent inhibitor of EPHA2/EPHA4 and GAK with KD values of 180.5 nM for EPHA2 and 19.2 nM for GAK, respectively. EPHA2/GAK-IN-1 shows an extrapolated half-life time of 4.6 h in a microsomal stability assay. EPHA2/GAK-IN-1 shows antiviral activity and prevents dengue virus infection of Huh7 liver cells .
loading...
    loading...
Referencia número: HY-P10412A
Synonyms: ANXA1-derived 11 amino acid-long peptide acetate
Áreas de investigación:  

Cancer

A11 (ANXA1-derived 11 amino acid-long peptide) acetate is a ANXA1-EphA2 interaction-blocking peptide. A11 acetate reduces ANXA1 bound to EphA2 and increases Cbl (the E3 ubiquitin ligase of EphA2) bound to EphA2. A11 acetate inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells. A11 acetate inhibits angiogenesis. A11 acetate can be used in studies related to nasopharyngeal carcinoma .
loading...
    loading...
Referencia número: HY-RS04426
Áreas de investigación:  

Others

EPHA2 Human Pre-designed siRNA Set A contains three designed siRNAs for EPHA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...